ImmunityBio appoints Patrick Soon-Shiong as Global Chief Scientific and Medical Officer; base salary $600k

ImmunityBio, Inc.

Dr. Patrick Soon-Shiong appointed as Global Chief Scientific and Medical Officer, a new executive position, effective Aug 11, 2021.
Soon-Shiong will also continue as Executive Chairman; receives base salary of $600k/year and bonus up to 50% of salary.
CFO David Sachs gets base salary increase from $397k to $475k, effective next payroll period.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Patrick Soon-Shiong

Global Chief Scientific and Medical Officer

IBRX · ImmunityBio, Inc.

Effective: 2021-08-11
Filed: August 13, 2021, 7:59 PM ET

appointed Patrick Soon-Shiong, M.D., as Global Chief Scientific and Medical Officer of the Company, a newly created executive position, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick Soon-Shiong was appointed as Global Chief Scientific and Medical Officer at ImmunityBio, Inc..

Action: appointed
Role: Global Chief Scientific and Medical Officer

Exact text from the filing

appointed Patrick Soon-Shiong, M.D., as Global Chief Scientific and Medical Officer of the Company, a newly created executive position, effective immediately.

View on SEC.gov

ImmunityBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-246082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.